Sumitomo Pharma Co., Ltd. DNPUF
11.91 USD 0.00 (+0.00%)
At close·Nov 3, 2026, 4:00 PM EST
Altman Z-Score
2.29 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E 8.0×
P/S 1.9×
P/B 2.9×
P/FCF 12.7×
EV/EBITDA 14.4×
EV/Sales 2.3×
FCF Yield 7.9%
Gross Margin 56.7%
Operating Margin 11.1%
Net Margin 23.6%
ROE 36.5%
ROIC 8.8%
ROA 13.3%
Revenue 14.4%
Operating Income 239.4%
EPS (diluted) 353.9%
Free Cash Flow 1846.1%
Current Ratio 1.0×
Quick Ratio 0.7×
Debt / Equity 0.7×
Net Debt / EBITDA 2.4×
Interest Coverage 4.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-03-31